Melanoma

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

This CME/CNE activity will discuss the role of checkpoint inhibitor therap…

Expiration Date: 2/16/2017

Max Credits: 0

View Activity

Managing Toxicities in the Treatment of Advanced Melanoma

Managing Toxicities in the Treatment of Advanced Melanoma

This CME/CNE activity will discuss the management of the toxicities of mel…

Expiration Date: 2/16/2017

Max Credits: 0

View Activity

Predictive Biomarkers for Immunotherapy: Where Are we?

Predictive Biomarkers for Immunotherapy: Where Are we?

The identification of a robust and reproducible biomarker, which can be us…

Expiration Date: 1/26/2018

Max Credits: 0

View Activity

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

The incidence of melanoma is continuing to increase worldwide. In recent y…

Expiration Date: 1/11/2017

Max Credits: 0

View Activity

Sequencing Targeted Therapy and Immunotherapy for Patients with Metastatic BRAFV600 Mutant Melanoma: How are We Going to Figure it Out?

Sequencing Targeted Therapy and Immunotherapy for Patients with Metastatic BRAFV600 Mutant Melanoma: How are We Going to Figure it Out?

Metastatic melanoma is one of the most challenging malignancies to treat. …

Expiration Date: 11/11/2016

Max Credits: 0

View Activity

Ipilimumab versus Placebo After Complete Resection of Stage III Melanoma: Results from the EORTC 18071 Phase III Trial

Ipilimumab versus Placebo After Complete Resection of Stage III Melanoma: Results from the EORTC 18071 Phase III Trial

In this CME activity, Dr. Alexander Eggermont discusses the EORTC 18071 ph…

Expiration Date: 11/5/2016

Max Credits: 0

View Activity

Unanswered Questions: What is the Role of Sentinel Node Biopsy in Desmoplastic Melanoma?

Unanswered Questions: What is the Role of Sentinel Node Biopsy in Desmoplastic Melanoma?

In this CME activity, Dr. Dale Han discusses recent clinical trial data on…

Expiration Date: 9/21/2017

Max Credits: 0

View Activity

Intralesional Therapy

Intralesional Therapy

This CME Activity evaluates the clinical safety and efficacy profiles of n…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity